According to AstraZeneca's latest financial reports the company's current EPS (TTM) is $1.98. In 2022 the company made an earnings per share (EPS) of $1.06 an increase over its 2021 EPS that were of $0.14.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.98 | 87.26% |
2022 | $1.06 | 631.03% |
2021 | $0.14 | -88.11% |
2020 | $1.22 | 136.89% |
2019 | $0.51 | -39.41% |
2018 | $0.85 | -28.27% |
2017 | $1.18 | -14.37% |
2016 | $1.38 | 24.11% |
2015 | $1.12 | 127.55% |
2014 | $0.49 | -51.96% |
2013 | $1.02 | -58.95% |
2012 | $2.48 | -32.2% |
2011 | $3.66 | 30.89% |
2010 | $2.80 | 7.9% |
2009 | $2.60 | 23.57% |
2008 | $2.10 | 12.3% |
2007 | $1.87 | -3.11% |
2006 | $1.93 | 32.65% |
2005 | $1.45 | -94.03% |
2004 | $24.35 | 2651.98% |
2003 | $0.89 | 7.93% |
2002 | $0.82 | 1.32% |
2001 | $0.81 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | 609.59% | ๐บ๐ธ USA |
Novartis NVS | $3.74 | 88.41% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | -6.30% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $2.97 | 49.73% | ๐บ๐ธ USA |
Eli Lilly LLY | $5.43 | 173.52% | ๐บ๐ธ USA |
Sanofi SNY | $3.18 | 60.21% | ๐ซ๐ท France |
Biogen BIIB | $18.46 | 829.97% | ๐บ๐ธ USA |
Merck MRK | $1.82 | -8.23% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $3.97 | 100.00% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $3.50 | 76.36% | ๐ฌ๐ง UK |